Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05288777 | Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer(Breast53) | recruiting | Phase 2 / Phase 3 | 45 | University of VirginiaOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT04892693 | Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency | recruiting | Phase 2 | 70 | Seoul National University HospitalOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT05536128 | Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor(Post-CDK) | recruiting | Phase 2 | 64 | Seoul National University HospitalOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06931548 | Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery | recruiting | N/A | 100 | Branch Office of "Hadassah Medical Ltd"OTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06926543 | Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy(CONCERT) | recruiting | Phase 3 | 858 | Dr. Tabassum WadasadawalaOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT04933266 | Subpectoral Plexus Block With Multi-level TPVB for Surgical Anesthesia During Primary Breast Cancer Surgery | recruiting | N/A | 100 | Chinese University of Hong KongOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT06073106 | Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention(OPTIMA-C) | recruiting | — | 500 | Tan Tock Seng HospitalOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT03870620 | Metastatic Breast Cancer in Austria | recruiting | — | 5,000 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT05450016 | Assessment of the Breast Cosmesis Using Deep Neural Networks: an Exploratory Study (ABCD)(ABCD) | recruiting | — | 720 | Tata Memorial CentreOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT06920810 | Viscum Album for TNBC on Adjuvant Pembrolizumab(TNBNOBA) | recruiting | Phase 4 | 40 | Ilsan Cha hospitalOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT01785420 | Pre Operative Trastuzumab in Operable Breast Cancer | recruiting | Phase 3 | 1,100 | Dr Rajendra A. BadweOTHER_GOV | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06918184 | Timing of Specific Exercise Therapy After Breast Cancer Surgery: Early Versus Delayed Initiation(BEST-Timing) | recruiting | N/A | 140 | Al Hayah University In CairoOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06918262 | Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer | recruiting | — | 40 | The First Hospital of Jilin UniversityOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT05013255 | Pioglitazone Therapy Targeting Fatigue in Breast Cancer | recruiting | Phase 2 | 30 | West Virginia UniversityOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT05406635 | Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer(HER2BIC) | recruiting | N/A | 220 | Odense University HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06006806 | Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy | recruiting | N/A | 100 | Covenant Health Cancer CenterOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT04680442 | Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction(SCHOLAR-2) | recruiting | Phase 2 | 130 | Population Health Research InstituteOTHER | 3 | Apr 6, 2025 | clinicaltrials |
| NCT05484973 | Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss | recruiting | N/A | 99 | Cooler Heads Care Inc.OTHER_GOV | 1 | Apr 6, 2025 | clinicaltrials |
| NCT05544240 | Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors | recruiting | Phase 1 | 20 | Williams Cancer FoundationOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06913244 | Long-Term Multidisciplinary Physiotherapy for Breast Cancer Survivors: A Randomized Controlled Trial | recruiting | N/A | 146 | Al Hayah University In CairoOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT04817566 | Cognitive Training and Brain Stimulation in Women With Post-chemotherapy Cognitive Impairment(NeuroMod-PCCI) | recruiting | N/A | 52 | University Medicine GreifswaldOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06911528 | Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast Cancer(EDGE) | recruiting | N/A | 709 | Fudan UniversityOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06908291 | Photoacoustic/Ultrasound Imaging for Breast Nodule Diagnosis, Molecular Classification, and Neoadjuvant Chemotherapy Response Evaluation | recruiting | N/A | 500 | Peking Union Medical College HospitalOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT04025541 | Analysis of Circulating Tumor Markers in Blood(ALCINA2) | recruiting | N/A | 992 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06900647 | Bortezomib Plus Cisplatin in Recurrent or Metastatic Breast Cancer(BOCIS) | recruiting | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06811870 | A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Breast Cancer Patients | recruiting | Phase 1 / Phase 2 | 161 | Guangdong Provincial People's HospitalOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06904989 | A New Cancer Rehabilitation Process for Chemotherapy-Induced Foot Neuropathy Using Orthopedic Devices(FOTNEV) | recruiting | N/A | 40 | Vastra Gotaland RegionOTHER_GOV | 1 | Apr 1, 2025 | clinicaltrials |
| NCT06895291 | Whole Body MRI in Oncology(ONCO-MRI) | recruiting | — | 1,000 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT05955170 | Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer(TUC-TOC) | recruiting | Phase 2 | 66 | Institut CurieOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT05416164 | DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy | recruiting | N/A | 595 | The Netherlands Cancer InstituteOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT05976815 | Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients(KEYMOVE) | recruiting | N/A | 86 | University Institute of MaiaOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06888258 | Compare Analgesia Between MTP Block And ESPB in MRM | recruiting | N/A | 90 | National Cancer Institute, EgyptOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06894173 | EvoLution of Neoadjuvant TreatMent in 'Triple-negative' or 'HER-2-positive' Breast Cancer Diagnosed in the EaRly Phase(GIM28-ELMER) | recruiting | — | 1,000 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT03671044 | A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients | recruiting | Phase 3 | 657 | Jina Pharmaceuticals Inc.INDUSTRY | 2 | Mar 21, 2025 | clinicaltrials |
| NCT05044689 | Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria | recruiting | — | 800 | Obafemi Awolowo University Teaching HospitalOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT05867966 | Psychoneurological Symptom Cluster in Oncology | recruiting | N/A | 500 | University of LiegeOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT05332561 | Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE) | recruiting | Phase 2 | 240 | German Cancer Research CenterOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT05485766 | Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer | recruiting | Phase 2 | 23 | Okayama UniversityOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06877416 | Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer | recruiting | — | 700 | Sun Yat-sen UniversityOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06880029 | Circadian Rhythm Impact on TNBC Response to Neoadjuvant Immunotherapy(CIRCADIAN) | recruiting | Phase 1 / Phase 2 | 20 | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.OTHER_GOV | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06883201 | Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer | recruiting | — | 78 | Regina Elena Cancer InstituteOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT05816655 | Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer | recruiting | Phase 2 | 202 | Korea University Guro HospitalOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT05465031 | Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) | recruiting | Phase 4 | 600 | Silesian Centre for Heart DiseasesOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT05968677 | Effect of an Amino Acids and Flavonoids Containing FSMP on Chemotherapy Toxicity, Nutritional Status and Quality of Life in Breast Cancer Patients | recruiting | N/A | 60 | Flavolife SrlINDUSTRY | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06780735 | Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy | recruiting | N/A | 128 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 13, 2025 | clinicaltrials |
| NCT04510129 | A Multicenter Cancer Biospecimen Collection Study | recruiting | — | 1,650 | Cofactor Genomics, Inc.INDUSTRY | 1 | Mar 12, 2025 | clinicaltrials |
| NCT05918328 | Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC | recruiting | Phase 2 | 610 | Henan Cancer HospitalOTHER_GOV | 1 | Mar 7, 2025 | clinicaltrials |
| NCT05899387 | Seroma of the Mammary Gland(SerMa) | recruiting | N/A | 2,000 | University Hospital AugsburgOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06193525 | FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test(FUTURE) | recruiting | Phase 2 | 66 | Erasmus Medical CenterOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06851299 | The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer. | recruiting | Phase 2 | 60 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 28, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Apr 18, 2025source: clinicaltrials